Tevogen (TVGN) Cash & Equivalents (2021 - 2026)
Tevogen's Cash & Equivalents came in at $692,305 for Q1 2026, down 64.9% from $1.97 million a year earlier but up 25.3% from the prior quarter.
Powered by 
Analysis
Tevogen (TVGN) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Tevogen's Cash & Equivalents was $552,372, down 56.9% from FY2024.
- Cash & Equivalents carries a four-year compound annual growth rate of 12.5% (FY2021 to FY2025).
- Going back by year, Cash & Equivalents was $1.28 million in FY2024 (+21.9%), $1.05 million in FY2023 (-80.8%), $5.48 million in FY2022 and $344,581 in FY2021.
- The five-year range for quarterly Cash & Equivalents is $143,047 (Q3 2022) to $5.67 million (Q1 2023).
- Year-over-year, Cash & Equivalents has declined for four consecutive quarters, with an average decline of 27.9% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2025 (growth of 49.9%), and the weakest in Q4 2023 (a decline of 80.8%).
- Business Quant data shows TVGN's Cash & Equivalents at $552,372 (Q4 2025), $1.04 million (Q3 2025) and $685,229 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Tevogen | 27.39 Mn | 24.42 Mn | - | 692,305.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 692,305.00 |
| Dec 31, 2025 | 552,372.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 685,229.00 |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 3.46 Mn |
| Mar 31, 2023 | 5.67 Mn |
| Dec 31, 2022 | 5.48 Mn |
| Sep 30, 2022 | 143,047.00 |
| Jun 30, 2022 | 185,645.00 |
| Mar 31, 2022 | 231,546.00 |
| Dec 31, 2021 | 344,581.00 |
API Access
Tevogen Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TVGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TVGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TVGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();